BRPI0700273A - material de implante - Google Patents
material de implanteInfo
- Publication number
- BRPI0700273A BRPI0700273A BRPI0700273-4A BRPI0700273A BRPI0700273A BR PI0700273 A BRPI0700273 A BR PI0700273A BR PI0700273 A BRPI0700273 A BR PI0700273A BR PI0700273 A BRPI0700273 A BR PI0700273A
- Authority
- BR
- Brazil
- Prior art keywords
- stearate
- palmitate
- amikacin
- tobramycin
- gentamicin
- Prior art date
Links
- 239000007943 implant Substances 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 9
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 abstract 8
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 abstract 3
- 229930182566 Gentamicin Natural products 0.000 abstract 3
- 229960004821 amikacin Drugs 0.000 abstract 3
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 abstract 3
- 229960002518 gentamicin Drugs 0.000 abstract 3
- 229940105132 myristate Drugs 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 abstract 3
- 229960000707 tobramycin Drugs 0.000 abstract 3
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 abstract 3
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 abstract 2
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 abstract 2
- KGZHFKDNSAEOJX-WIFQYKSHSA-N Ramoplanin Chemical compound C([C@H]1C(=O)N[C@H](CCCN)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(N[C@@H](C(=O)N[C@H](CCCN)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)[C@H](C)O)C=1C=CC(O)=CC=1)C=1C=CC(O)=CC=1)[C@@H](C)O)C=1C=CC(O)=CC=1)=O)NC(=O)[C@H](CC(N)=O)NC(=O)\C=C/C=C/CC(C)C)C(N)=O)C=1C=C(Cl)C(O)=CC=1)C=1C=CC(O)=CC=1)[C@@H](C)O)C=1C=CC(O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC=1)C1=CC=CC=C1 KGZHFKDNSAEOJX-WIFQYKSHSA-N 0.000 abstract 2
- 108010059993 Vancomycin Proteins 0.000 abstract 2
- 230000003115 biocidal effect Effects 0.000 abstract 2
- 229960002227 clindamycin Drugs 0.000 abstract 2
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 abstract 2
- 229960003376 levofloxacin Drugs 0.000 abstract 2
- 229960003702 moxifloxacin Drugs 0.000 abstract 2
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 abstract 2
- 229960001699 ofloxacin Drugs 0.000 abstract 2
- 229950003551 ramoplanin Drugs 0.000 abstract 2
- 108010076689 ramoplanin Proteins 0.000 abstract 2
- 229960003165 vancomycin Drugs 0.000 abstract 2
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 abstract 2
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 abstract 2
- 238000002513 implantation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Physical Vapour Deposition (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Inorganic Insulating Materials (AREA)
Abstract
MATERIAL DE IMPLANTE. A presente invenção refere-se a corpos moldados, moldados por rotação simétrica ou irregularmente moldados, consistindo em pelo menos um membro do grupo dos sais antibióticos miristato de gentamicina, palmitato de gentamicina, estearato de gentamicina, miristato de tobramicina, palmitato de tobramicina, estearato de tobramicina, miristato de amicacina, palmitato de amicacina, estearato de amicacina, palmitato de vancomicina, estearato de vancomicina, palmitato de ramoplanina, estearato de ramoplanina, palmitato de levofloxacina, estearato de levofloxacina, palmitato de ofloxacina, estearato de ofloxacina, palmitato de monofloxacina, estearato de moxifloxacina, palmitato de clindamicina, e estearato de clindamicina, um dispositivo medicinal para implantação, no qual os corpos moldados são dispostos em fios biodegradáveis a uma distância de 1 mm até 25 mm, assim como um processo para preparação do dispositivo medicinal.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006007245A DE102006007245A1 (de) | 2006-02-15 | 2006-02-15 | Implantatmaterial |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0700273A true BRPI0700273A (pt) | 2007-11-06 |
Family
ID=37903579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0700273-4A BRPI0700273A (pt) | 2006-02-15 | 2007-02-14 | material de implante |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7858109B2 (pt) |
| EP (1) | EP1820496B1 (pt) |
| JP (1) | JP5226956B2 (pt) |
| CN (1) | CN101023926A (pt) |
| AT (1) | ATE527992T1 (pt) |
| AU (1) | AU2007200395B2 (pt) |
| BR (1) | BRPI0700273A (pt) |
| CA (1) | CA2570758C (pt) |
| DE (1) | DE102006007245A1 (pt) |
| DK (1) | DK1820496T3 (pt) |
| ES (1) | ES2374976T3 (pt) |
| PL (1) | PL1820496T3 (pt) |
| PT (1) | PT1820496E (pt) |
| ZA (1) | ZA200701306B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010020940B4 (de) * | 2010-05-19 | 2014-09-25 | Heraeus Medical Gmbh | Antibiotische Beschichtung |
| PL2529763T3 (pl) * | 2011-06-03 | 2017-06-30 | Waldemar Link Gmbh & Co. Kg | Sposób wytwarzania powłoki implantu i odpowiedniego implantu |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2320373B2 (de) | 1973-04-21 | 1978-04-06 | Merck Patent Gmbh, 6100 Darmstadt | Antibioticahaltiges Mittel und seine Verwendung als chirurgisches Kunststoffmaterial |
| DE2651441C2 (de) | 1976-11-11 | 1987-01-08 | Merck Patent Gmbh, 6100 Darmstadt | Antibioticahaltiges Mittel |
| DE3037270A1 (de) | 1980-10-02 | 1982-05-19 | Ulatowski, Lothar, Dr.med., 5630 Remscheid | Fibrinantibiotikumverbundketten |
| DE4404018A1 (de) * | 1994-02-09 | 1995-08-10 | Merck Patent Gmbh | Protrahiert freisetzende Darreichungsformen enthaltend Clindamycin-Palmitat |
| SE9401169L (sv) * | 1994-04-08 | 1995-10-09 | Corimed Gmbh | Förfarande för framställning av ett antibekteriellt aktivt ämne samt användning därav |
| US5756127A (en) * | 1996-10-29 | 1998-05-26 | Wright Medical Technology, Inc. | Implantable bioresorbable string of calcium sulfate beads |
| DE10114364A1 (de) * | 2001-03-22 | 2002-10-02 | Heraeus Kulzer Gmbh & Co Kg | Verfahren zur Herstellung von antibiotischen Kompositen |
| DE10114244A1 (de) | 2001-03-22 | 2002-10-02 | Heraeus Kulzer Gmbh & Co Kg | Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung |
| WO2003000156A1 (en) * | 2001-06-22 | 2003-01-03 | Southern Biosystems, Inc. | Zero-order prolonged release coaxial implants |
| US6648849B2 (en) * | 2001-06-27 | 2003-11-18 | Ethicon, Inc. | Medicinal implant and device and method for loading and delivering implants containing drugs and cells |
| DE10262176B4 (de) * | 2002-06-21 | 2007-10-04 | Heraeus Kulzer Gmbh | Verfahren zur Herstellung von antibiotisch beschichteten porösen Körpern sowie Verwendung |
| US7393687B2 (en) * | 2004-07-16 | 2008-07-01 | William Marsh Rice University | Biomimetic 3-dimensional scaffold with metabolic stream separation for bioartificial liver device |
-
2006
- 2006-02-15 DE DE102006007245A patent/DE102006007245A1/de not_active Withdrawn
- 2006-12-11 CA CA2570758A patent/CA2570758C/en not_active Expired - Fee Related
-
2007
- 2007-01-25 DK DK07001576.3T patent/DK1820496T3/da active
- 2007-01-25 ES ES07001576T patent/ES2374976T3/es active Active
- 2007-01-25 AT AT07001576T patent/ATE527992T1/de active
- 2007-01-25 EP EP07001576A patent/EP1820496B1/de not_active Not-in-force
- 2007-01-25 PT PT07001576T patent/PT1820496E/pt unknown
- 2007-01-25 PL PL07001576T patent/PL1820496T3/pl unknown
- 2007-01-31 AU AU2007200395A patent/AU2007200395B2/en not_active Ceased
- 2007-02-13 CN CNA2007100852209A patent/CN101023926A/zh active Pending
- 2007-02-14 ZA ZA200701306A patent/ZA200701306B/xx unknown
- 2007-02-14 JP JP2007033569A patent/JP5226956B2/ja not_active Expired - Fee Related
- 2007-02-14 BR BRPI0700273-4A patent/BRPI0700273A/pt not_active IP Right Cessation
- 2007-02-15 US US11/675,127 patent/US7858109B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007217413A (ja) | 2007-08-30 |
| CA2570758A1 (en) | 2007-08-15 |
| CN101023926A (zh) | 2007-08-29 |
| ES2374976T3 (es) | 2012-02-23 |
| PT1820496E (pt) | 2012-01-13 |
| EP1820496A3 (de) | 2008-07-09 |
| AU2007200395B2 (en) | 2007-11-29 |
| US20070190109A1 (en) | 2007-08-16 |
| EP1820496A2 (de) | 2007-08-22 |
| AU2007200395A1 (en) | 2007-08-30 |
| ATE527992T1 (de) | 2011-10-15 |
| ZA200701306B (en) | 2008-07-30 |
| US7858109B2 (en) | 2010-12-28 |
| CA2570758C (en) | 2011-07-19 |
| JP5226956B2 (ja) | 2013-07-03 |
| DE102006007245A1 (de) | 2007-08-23 |
| PL1820496T3 (pl) | 2012-03-30 |
| EP1820496B1 (de) | 2011-10-12 |
| DK1820496T3 (da) | 2012-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04006731A (es) | Sistema de administracion de farmacos que comprenden rapamicina y derivados de la misma para la prevencion y tratamiento de enfermedades vasculares. | |
| WO2008137237A3 (en) | Method for forming crystallized therapeutic agents on a medical device | |
| BR0213398A (pt) | Sal de alendronato, alendronato monossódico, processos para a produção dos mesmos, composição farmacêutica, e, método para inibição da ressorção óssea em um paciente | |
| WO2008039917A3 (en) | Method for sterilising minocycline- and rifampin-containing medical device | |
| BRPI0700273A (pt) | material de implante | |
| BR0301708A (pt) | Preparação farmacêutica com liberação de substância ativas retardada, processo para produção e uso da mesma | |
| BR0213154A (pt) | Compostos de glicopeptìdeo - cefalosporina de ligação reticulada, composições farmacêuticas de tais compostos, método de fabricação dos mesmos e seus usos | |
| ATE556088T1 (de) | Konjugat beinhaltend cephalosporin und glykopeptidantibiotikum | |
| WO2006081289A3 (en) | Antibacterial agents | |
| ZA200801171B (en) | 3, IIB-CIS-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation | |
| WO2006081182A3 (en) | Antibacterial agents | |
| CY1110027T1 (el) | Συνδυασμος ενωσεων πυριμιδυλαμινοβενζαμιδης και ιματινιβης για τη θεραπεια ή την προληψη των νεοπλασματικων ασθενειων | |
| AR027853A1 (es) | Composicion para revestimiento hidrofilica, enlazada convalentemente, para implantes quirurgicos, el implante y el metodo para revestirlo. | |
| WO2006081178A3 (en) | Antibacterial agents | |
| AU2012264783B2 (en) | Method for producing an implant coating, and corresponding implant | |
| MX2008010804A (es) | Derivados de rapamicina para tratar neuroblastoma. | |
| BRPI0511262A (pt) | combinação de compostos orgánicos | |
| DE602006010565D1 (de) | Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält | |
| RU2575573C2 (ru) | Способ получения покрытия на импланте и соответствующий имплант | |
| CL2008003758A1 (es) | Compuestos derivados de 1(2)h-tetrazol-5-il-fenil-oxazolidinonas, procedimiento de preparacion, composicion farmaceutica, util para el tratamiento de infecciones bacterianas. | |
| Kanellakopoulou et al. | In vitro elution of moxifloxacin from cancellous bone allografts | |
| AU2021900922A0 (en) | Implant device, system and method for treating disease | |
| AU2020900938A0 (en) | Implant device, system and method for treating disease | |
| WO2007010012A3 (en) | Combination of a pyrimidylaminobenzamide and an mtor kinase inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: HERAEUS MEDICAL GMBH (DE) |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2364 DE 26-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |